{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-178824","form_type":"8-K","ticker":"BEAM","cik":"0001745999","company_name":"Beam Therapeutics Inc.","filed_at":"2024-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.390030+00:00","generated_at":"2026-05-31T20:43:21.785757+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Beam Therapeutics CFO Terry-Ann Burrell resigns; CEO John Evans named interim principal financial officer","bullets":["CFO Terry-Ann Burrell resigns effective Aug 9, 2024 to join JPMorgan as vice chairman of investment banking.","CEO John Evans appointed Principal Financial and Accounting Officer upon her departure, continuing as CEO.","Company initiates search for a permanent CFO successor.","Burrell had served as CFO for 5 years, overseeing IPO and capital raising efforts."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-178824","json":"https://secwatch.observer/filing/0001193125-24-178824.json","markdown":"https://secwatch.observer/filing/0001193125-24-178824.md","text":"https://secwatch.observer/filing/0001193125-24-178824.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/d723042d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:43:21.785757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0a5c2cc26b","claim":"John Evans was appointed as Principal Financial and Accounting Officer at Beam Therapeutics Inc..","evidence_excerpt":"Effective upon Ms. Burrell’s resignation, John Evans, the Company’s Chief Executive Officer and a member of the Company’s board of directors, was appointed Principal Financial and Accounting Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial and Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"306f108c11","claim":"Terry-Ann Burrell resigned as Chief Financial Officer and Treasurer at Beam Therapeutics Inc..","evidence_excerpt":"Terry-Ann Burrell notified Beam Therapeutics Inc. (the “Company”) of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1745999/000119312524178824/0001193125-24-178824-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer and Treasurer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}